Steve Oh

Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.

Quantitative identification of teratoma tissues formed by human embryonic stem cells with TeratomEye.

Identification of cellular objective for elucidating the physiological state of plasmid-bearing Escherichia coli using genome-scale in silico analysis.

Long-term microcarrier suspension cultures of human embryonic stem cells.

KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.

Defined and serum-free media support undifferentiated human embryonic stem cell growth.

Investigations into the metabolism of two-dimensional colony and suspended microcarrier cultures of human embryonic stem cells in serum-free media.

Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures.

Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures.

Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells.

Expansion of human embryonic stem cells on cellulose microcarriers.

Impact of vitronectin concentration and surface properties on the stable propagation of human embryonic stem cells.

Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells.

Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells.

Translating Human Embryonic Stem Cells from 2-Dimensional to 3-Dimensional Cultures in a Defined Medium on Laminin- and Vitronectin-Coated Surfaces.

Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.

Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures.

Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells.

Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction.

Inhibition of ROCK-myosin II signaling pathway enables culturing of human pluripotent stem cells on microcarriers without extracellular matrix coating.

Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays.

Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures.

An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.

Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling.

Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.

Serum-free media formulations are cell line-specific and require optimization for microcarrier culture.

Integrated processes for expansion and differentiation of human pluripotent stem cells in suspended microcarriers cultures.

Recent advances in serum-free microcarrier expansion of mesenchymal stromal cells: Parameters to be optimized.

Fabrication of uniform-sized poly-ɛ-caprolactone microspheres and their applications in human embryonic stem cell culture.

Enhanced in vitro osteogenic differentiation of human fetal MSCs attached to 3D microcarriers versus harvested from 2D monolayers.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells.

Genome-Wide Transcriptome and Binding Sites Analyses Identify Early FOX Expressions for Enhancing Cardiomyogenesis Efficiency of hESC Cultures.

Biodegradable ECM-coated PCL microcarriers support scalable human early MSC expansion and in vivo bone formation.

Biodegradable poly-ε-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors.

Tunable Volumetric Density and Porous Structure of Spherical Poly-ε-caprolactone Microcarriers, as Applied in Human Mesenchymal Stem Cell Expansion.

Critical attributes of human early mesenchymal stromal cell-laden microcarrier constructs for improved chondrogenic differentiation.

Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.

Erratum: Identification of Na/K-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides.

Immobilization of vitronectin-binding heparan sulfates onto surfaces to support human pluripotent stem cells.

Improved erythroid differentiation of multiple human pluripotent stem cell lines in microcarrier culture by modulation of Wnt/β-Catenin signaling.

Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3β Inhibitor CHIR99021 in Human Pluripotent Stem Cells.

Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess.

Inertial-Based Filtration Method for Removal of Microcarriers from Mesenchymal Stem Cell Suspensions.

Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges.

Scaled-Up Inertial Microfluidics: Retention System for Microcarrier-Based Suspension Cultures.

Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect.

Rapid Detection of Senescent Mesenchymal Stromal Cells by a Fluorescent Probe.

Human mesenchymal stem cell therapy for cartilage repair: Review on isolation, expansion, and constructs.

Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.

Machine learning to predict mesenchymal stem cell efficacy for cartilage repair.

A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.

Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures.

Integrating Human-Induced Pluripotent Stem Cell Expansion Capability and Cardiomyocyte Differentiation Potential in a Microcarrier Suspension Culture.

Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions.

Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion.

Selection of O-negative induced pluripotent stem cell clones for high-density red blood cell production in a scalable perfusion bioreactor system.